![]() |
Volumn 20, Issue 31, 2001, Pages 4128-4137
|
CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release
|
Author keywords
Apoptosis; Brain; Cytokines; Immunotherapy; Neuroimmunology
|
Indexed keywords
CISPLATIN;
CYCLOHEXIMIDE;
CYTOCHROME C;
DOXORUBICIN;
HYGROMYCIN;
LOMUSTINE;
PROTEIN P53;
PROTEIN SYNTHESIS INHIBITOR;
PUROMYCIN;
TEMOZOLOMIDE;
TENIPOSIDE;
TOPOTECAN;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
VINCRISTINE;
APOPTOSIS;
ARTICLE;
CANCER IMMUNOTHERAPY;
CELL KILLING;
CONTROLLED STUDY;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME RELEASE;
GLIOMA CELL;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ANTINEOPLASTIC AGENTS, ALKYLATING;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
BLOTTING, WESTERN;
BRAIN NEOPLASMS;
CASPASE 8;
CASPASE 9;
CASPASES;
CYTOCHROME C GROUP;
FLOW CYTOMETRY;
GLIOMA;
HUMANS;
LOMUSTINE;
MEMBRANE GLYCOPROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TNF-RELATED APOPTOSIS-INDUCING LIGAND;
TUMOR CELLS, CULTURED;
TUMOR NECROSIS FACTOR-ALPHA;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0035849785
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204534 Document Type: Article |
Times cited : (97)
|
References (27)
|